To Evaluate the Safety and Pharmacokinetics of BMS-986177 in Healthy Japanese Participants

Inclusion Criteria:

- Participants must be first-generation Japanese (born in Japan and not living outside
of Japan for > 10 years; both parents must be ethnically Japanese)

- Body Mass Index 18.0 to 25.0 kg/m2, inclusive

- Women must not be of nonchildbearing potential (cannot become pregnant)

Exclusion Criteria:

- Any significant acute or chronic medical illness

- History of allergy to BMS-986177 or other factor Xia inhibitors and/or formulation
excipients or history of any significant drug allergy (such as anaphylaxis or
hepatotoxicity)

- History or evidence of abnormal bleeding or coagulation disorder

Other protocol defined inclusion and exclusion criteria apply